Evidence mapPaperPMID 12401758Full record

ArticleDiabetes care2002

Acute effect of glimepiride on insulin-stimulated glucose metabolism in glucose-tolerant insulin-resistant offspring of patients with type 2 diabetes.

Dietrich Overkamp, Annette Volk, Elke Maerker, Peter E Heide, Hans G Wahl, Kristian Rett, Hans U Häring

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Diabetes care, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02026310 (Efficacy/Safety Study of Adding Glimepiride to Type 2 Diabetes Patients With Inadequate Glycemic Control Based on Combination With Metformin And Basal Insulin), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02026310 nacompletedstarted 2014, after this paper: background citation

Efficacy/Safety Study of Adding Glimepiride to Type 2 Diabetes Patients With Inadequate Glycemic Control Based on Combination With Metformin And Basal Insulin

Ran2014Enrolled40Registered outcomes2Posted comparisons0ConditionsDiabetes Mellitus, Type 2Armsglargine and metformin, Glimepiride
Open the trial in the graph
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. [Perioperative handling of antidiabetic drugs].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2018
    Review
  5. Pancreatic regulation of glucose homeostasis.Experimental & molecular medicine · 2016
    Review
  6. Sulfonylureas: a new look at old therapy.Current diabetes reports · 2014
    Review
  7. Review
  8. Article
  9. [Future targets in the treatment of type 2 diabetes].Wiener klinische Wochenschrift · 2004
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Dietrich OverkampDepartment of Internal Medicine IV, Tübingen, Germany. dietrih.overkamp@med.uni-tuebingen.de
Annette Volk
Elke Maerker
Peter E Heide
Hans G Wahl
Kristian Rett
Hans U Häring
University of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study addressed whether acute infusion of glimepiride influences glucose metabolism independent of its effect on insulin secretion. RESEARCH DESIGN AND

methodsTen healthy, glucose-tolerant but insulin-resistant probands were subjected to a placebo-controlled, double-blind, cross-over study. Each individual received infusions of either 0.15 mol/l saline or glimepiride in randomized order on two separate occasions. A three-step hyperinsulinemic (0.5, 1.0, and 1.5 mU. kg(-1). min(-1))-euglycemic glucose clamp was performed on both occasions to determine insulin sensitivity. Glimepiride-induced insulin secretion was inhibited by octreotide. Endogenous glucose production and glucose elimination were measured with the "hot" glucose infusion method using U-[(13)C]glucose as tracer. Glucose oxidation was determined from indirect calorimetry. Lipolysis was evaluated by measurements of nonesterified fatty acid (NEFA) and glycerol concentration and measurement of glycerol production.

resultsPlasma glucose and insulin concentrations were not significantly different between glimepiride or saline infusions. There was a significant increase in the rate of glucose infusion necessary to maintain euglycemia during infusion of glimepiride during the low- (12.2 +/- 1.1 vs. 16.1 +/- 1.7 micro mol. kg(-1). min(-1)) and intermediate-dose insulin infusion (24.4 +/- 1.7 vs. 30.0 +/- 2.8 micro mol. kg(-1). min(-1)). This was explained by an increased rate of glucose elimination and to a lesser degree by a decrease in glucose production. Glucose oxidation rate was not different. NEFA and glycerol concentration and glycerol production were equally suppressed.

conclusionsGlimepiride improves peripheral glucose uptake and decreases endogenous glucose production independent of its insulin secretagogue action. The effects shown in this acute study are, however, too small to be considered therapeutically beneficial for the individual patient.

Indexed as

Blood GlucoseC-PeptideDiabetes Mellitus, Type 2FemaleGlucose Clamp TechniqueHumansHypoglycemic AgentsInsulinKineticsMaleMetabolic Clearance RateNuclear FamilyReference ValuesSulfonylurea CompoundsBlood GlucoseC-PeptideglimepirideHypoglycemic AgentsInsulinSulfonylurea Compounds

Identifiers

PMID12401758
OpenAlexW2010279721

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.